rf-fullcolor.png

 

January 12, 2015
by Stewart Eisenhart

Mexico's COFEPRIS Exempts Hundreds of Devices from Registration Requirements

Content provided by Emergo, a medical device regulatory affairs and quality assurance consulting firm with offices worldwide.

Mexican regulators have expanded their list of healthcare products that do not require registration and approval to be sold in the country.

COFEPRIS, Mexico’s medical device market regulator, added 573 items to its list of products (link in Spanish) not considered medical devices, effectively removing registration as a requirement for importation, distribution or sale of these products in Mexico. Most of the products added to the no-registration list share low-risk profiles, or are components or accessories to other medical devices.

Products most recently added to Mexico’s no-registration list include patient positioning equipment, artificial teeth and staining solutions, as well as automatic and manual patient beds, hardware and cables for monitors and reagent cartridges. Most notably, standalone software remains on the list of products not required to register with COFEPRIS.

The breadth of medical products added to the COFEPRIS list will impact a wide swath of manufacturers now able to commercialize their goods in Mexico with significantly less market authorization requirements.

For more information, see our video overview of the Mexican medical device registration process.

 

Read the Original Blog Post at Emergo

Related: Mexico Updates Lists of Class Ia Devices, Third-Party Reviewers

Related: COFEPRIS Device Seizures Demonstrate Importance of Proper Medical Device Labeling in Mexico

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.